Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • weightbayou weightbayou Apr 4, 2013 4:34 PM Flag

    Celldex owns today's immunotherapy conference.

    2:00 pm - 4:30 pm Session V: Making the System Work - Economic and Intellectual Challenges and Solutions
    Co-Chairs
    Martin A. "Mac" Cheever, MD - Fred Hutchinson Cancer Research Center
    Thomas Davis, MD - Celldex Therapeutics, Inc.
    Panel Discussion
    Martin A. "Mac" Cheever, MD - Fred Hutchinson Cancer Research Center
    Daniel S. Chen, MD, PhD - Genentech
    Gwen Darien - The Pathways Project
    Thomas Davis, MD - Celldex Therapeutics, Inc.
    Eric Rubin, MD - Merck & Company, Inc.
    Jonathan Skipper, PhD - Ludwig Institute for Cancer Research
    4:30 pm - 5:00 pm Summary and Conclusion
    Thomas A. Davis, MD - Celldex Therapeutics, Inc.
    Samir N. Khleif, MD - Georgia Regents University
    Howard Streicher, MD - National Institutes of Health

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Anybody know how that presentation went and what was discussed? Great that we are in the discussion, If anyone attended it woudl be nice if they posted a blurb on it.

      Sentiment: Strong Buy

      • 2 Replies to mymandon
      • I wish I knew how many people attended. I am surprised Celldex did not mention this on their website or in a PR. I guess things are going so well for them they are not concerned with something so mundane as a PR.

        Sentiment: Strong Buy

      • Celldex's Thomas Davis is scheduled to participate on a disccussion panel - Session V: Making the System Work - Economic and Intellectual Challenges and Solutions, at 2:00 p.m. I do not think that this will bring out any new information on any of CLDX products...it seems to be a general discussion about the current challenges that oncology biotechs face in today's markets.

 
CLDX
3.99-0.24(-5.67%)Sep 28 4:00 PMEDT